T. Rowe Price Associates, Inc. 13D and 13G filings for Tenaya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | TENAYA THERAPEUTICS INC TNYA | T. Rowe Price Associates, Inc. | 3,028,435 3.800% | -1,516,108 (-33.36%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | TENAYA THERAPEUTICS INC TNYA | T. Rowe Price Associates, Inc. | 4,544,543 6.700% | 72,341 (+1.62%) | Filing |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | TENAYA THERAPEUTICS INC TNYA | T. Rowe Price Associates, Inc. | 4,472,202 6.700% | 1,478,699 (+49.40%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | TENAYA THERAPEUTICS INC TNYA | T. Rowe Price Associates, Inc. | 2,993,503 7.200% | 2,993,503 (New Position) | Filing |